The adjacent flanking region plays a critical role in facilitating the presentation of the Listeria monocytogenes product lemA to H2 M3(wt)- restricted, peptide-specific murine CD8 cells

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6741-6747

  Kurlander, Roger J ^a   Chao, Elizabeth ^a   Fields, Janet ^a   Nataraj, Chandrasekaran ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CD8 ANTIGEN; CHLOROQUINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPSTATIN; PROTEINASE K;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA FLANKING REGION; LISTERIA MONOCYTOGENES; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOPLASM; ENDOPEPTIDASE K; EPITOPES, T-LYMPHOCYTE; FIBROBLASTS; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; LISTERIA MONOCYTOGENES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; PEPTIDE FRAGMENTS; TRANSCRIPTION FACTORS;

EID: 0032757512     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Lindahl, K. F., D. E. Byers, V. M. Dabhi, R. Hovik, E. P. Jones, G. P. Smith, C. R. Wang, H. Xiao, and M. Yoshino. 1997. H2-M3, a full-service class Ib histocompatibility antigen. Annu. Rev. Immunol. 15:851.
2. Shawar, S. M., J. M. Vyas, J. R. Rodgers, and R. R. Rich. 1994. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12:839.
3. Vyas, J. M., S. M. Shawar, J. R. Rodgers, R. G. Cook, and R. R. Rich. 1992. Biochemical specificity of H-2 M3a: stereospecificity and space-filling requirements at position I maintain N-formyl peptide binding. J. Immunol. 149:3605.
4. Wang, C. R., K. F. Lindahl, and J. Deisenhofer. 1996. Crystal structure of the MHC class Ib molecule H2-M3. Res. Immunol. 147:313.
5. Lenz, L. L., B. Dere, and M. J. Bevan. 1996. Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity 5:63.
6. Kurlander, R. J., S. M. Shawar, M. L. Brown, and R. R. Rich. 1992. Specialized role for a murine class 1-b MHC molecule in prokaryotic host defenses. Science 257:678.
7. w1-restricted, Listeria monocytogenes-immune CD8 T cells respond to multiple formylated peptides and to a variety of Gram-positive and Gram-negative bacteria. Int. Immunol. 10:7.
8. Gulden, P. H., P. Fischer, 3rd, N. E. Sherman, W. Wang, V. H. Engelhard, J. Shabanowitz, D. F. Hunt, and E. G. Pamer. 1996. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity 5:73.
9. Princiolta, M. F., L. L. Lenz, M. J. Bevan, and U. D. Staerz. 1998. H2-M3 restricted presentation of a Listeria-derived leader peptide. J. Exp. Med. 187:1711.
10. Pamer, E. G., A. J. Sijts, M. S. Villanueva, D. H. Busch, and S. Vijh. 1997. MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses. Immunol. Rev. 158:129.
11. Brown, M. L., P. E. Fields, and R. J. Kurlander. 1992. Metabolic requirements for macrophage presentation of Listeria monocytogenes to immune CD8 cells. J. Immunol. 148:555.
12. Jondal, M., R. Schirmbeck, and J. Reimann. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5:295.
13. Harding, C. V. 1996. Class I MHC presentation of exogenous antigens. J. Clin. Immunol. 16:90.
14. + T cells with cytolytic and protective activity. J. Immunol. 140:3173.
15. Lenz, L. L., and M. J. Bevan. 1996. H2-M3 restricted presentation of Listeria monocytogenes antigens. Immunol. Rev. 151:107.
16. Lenz, L. L., and M. J. Bevan. 1997. CTL responses to H2-M3-restricted Listeria epitopes. Immunol. Rev. 158:115.
17. w1-restricted, Listeria monocytogenes-specific CD8 T cells recognize a novel, hydrophobic, protease-resistant, periodate-sensitive antigen. Int. Immunol. 8:367.
18. Meinnel, T., Y. Mechulam, and S. Blanquet. 1993. Methionine as translation start signal: a review of the enzymes of the pathway in Escherichia coli. Biochimie 75:1061.
19. + T cells. Cell 71:1205.
20. Bishop, D. K., and D. J. Hinrichs. 1987. Adoptive transfer of immunity to Listeria monocytogenes: the influence of in vitro stimulation on lymphocyte subset requirements. J. Immunol. 139:2005.
21. + T cells requires secretion of hemolysin and intracellular bacterial growth. J. Immunol. 145:3540.
22. Day, P. M., J. W. Yewdell, A. Porgador, R. N. Germain, and J. R. Bennink. 1997. Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. Proc. Natl. Acad. Sci. USA 94:8064.
23. Shastri, N., and F. Gonzalez. 1993. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. J. Immunol. 150:2724.
24. Smith, G. P., V. M. Dabhi, E. G. Pamer, and K. Fischer Lindahl. 1994. Peptide presentation by the MHC class Ib molecule, H2-M3. Int. Immunol. 6:1917.
25. Wang, C. R., B. E. Loveland, and K. F. Lindahl. 1991. H-2 M3 encodes the MHC class I molecule presenting the maternally transmitted antigen of the mouse. Cell 66:335.
26. d major histocompatibility complex class I chimera. J. Exp. Med. 179:155.
27. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
28. Carbone, F. R., and M. J. Bevan. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171:377.
29. Craiu, A., M. Gaczynska, T. Akopian, C. F. Gramm, G. Fenteany, A. L. Goldberg, and K. L. Rock. 1997. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 272:13437.
30. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17:131.
31. Harding, C. V., D. S. Collins, O. Kanagawa, and E. R. Unanue. 1991. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol. 147:2860.
32. van Binnendijk, R. S., C. A. van Baalen, M. C. M. Poelen, P. de Vries, J. Boes, V. Cerundolo, D. M. E. Osterhaus, and G. C. M. UytdeHaag. 1992. Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I-and class II-restricted cytotoxic T cell recognition. J. Exp. Med. 176:119.
33. Kovacsovics-Bankowski, M., K. Clark, B. Benacerraf, and K. L. Rock. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 90:4942.
34. Harding, C. V., and R. Song. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:4925.
35. Norbury, C. C., L. J. Hewlett, A. R. Prescott, N. Shastri, and C. Watts. 1995. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bore marrow macrophages, Immunity 3:783.
36. Norbury, C. C., B. J. Chambers, A. R. Prescott, H. G. Ljunggren, and C. Watts. 1997. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27:280.
37. von Heijne, G. 1989. Control of topology and mode of assembly of a polytopic membrane protein by positively charged residues. Nature 341:456.
38. Diment, S. 1990. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. J. Immunol. 145:417.
39. Song, R., and C. V. Harding. 1996. Roles of proteasomes, transporter for antigen presentation (TAP), and β2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J. Immunol. 156:4182.
40. Schirmbeck, R., K. Melber, and J. Reimann. 1995. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 25:1063.
41. Zhou, X., R. Glas, F. Momburg, G. J. Hammerling, M. Jondal, and H. G. Ljunggren. 1993. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes. Eur. J. Immunol. 23:1796.
42. Bachmann, M. F., A. Oxenius, H. Pircher, H. Hengartner, P. A. Ashton-Richardt, S. Tonegawa, and R. M. Zinkernagel. 1995. TAP1-independent loading of class I molecules by exogenous viral proteins. Eur. J. Immunol. 25:1739.
43. Schirmbeck, R., W. Bohm, and J. Reimann. 1997. Stress protein (hsp73)-mediated, TAP-independent processing of endogenous, truncated SV40 large T antigen for Db-restricted peptide presentation. Eur. J. Immunol. 27:2016.
44. d-restricted epitope presentation depends on exogenous β2-microglobulin. Eur. J. Immunol. 27:3471.
45. Schirmbeck, R., W. Bohm, K. Melber, and J. Reimann. 1995. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J. Immunol. 155:4676.
46. Sugita, M., R. M. Jackman, E. van Donselaar, S. M. Behar, R. A. Rogers, P. J. Peters, M. B. Brenner, and S. A. Porcelli. 1996. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science 273:349.
47. Wang, C. R., and K. F. Lindahl. 1993. HMT, encoded by H-2 M3, is a neoclassical major histocompatibility class I antigen. Proc. Natl. Acad. Sci. USA 90:2784.
48. Pond, L., and C. Watts. 1997. Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface. J. Immunol. 159:543.